Aveanna Healthcare (NASDAQ:AVAH) CEO Jeff Shaner Sells 27,929 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock in a transaction on Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total transaction of $233,486.44. Following the sale, the chief executive officer directly owned 2,451,210 shares of the company’s stock, valued at approximately $20,492,115.60. This trade represents a 1.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Jeff Shaner also recently made the following trade(s):

• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $226,373.32.

Aveanna Healthcare Stock Down 1.1%

Shares of NASDAQ AVAH opened at $8.08 on Friday. The business has a 50-day moving average of $8.92 and a two-hundred day moving average of $7.49. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The business had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. On average, analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Jump Financial LLC acquired a new position in shares of Aveanna Healthcare in the first quarter valued at approximately $59,000. Walleye Capital LLC grew its position in Aveanna Healthcare by 268.9% in the 1st quarter. Walleye Capital LLC now owns 51,470 shares of the company’s stock valued at $279,000 after buying an additional 37,517 shares during the last quarter. MetLife Investment Management LLC increased its stake in Aveanna Healthcare by 16.2% in the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after buying an additional 4,349 shares during the period. AQR Capital Management LLC increased its stake in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares during the period. Finally, Banque Transatlantique SA purchased a new position in Aveanna Healthcare during the 1st quarter worth $25,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on AVAH shares. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday. UBS Group boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. Truist Financial upped their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research report on Friday, November 7th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 price target on shares of Aveanna Healthcare in a research report on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Hold” and an average price target of $10.69.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.